Cloyd Jordan M, Norton Jeffrey A, Visser Brendan C, Poultsides George A
Department of Surgery, Stanford University, Stanford, CA, USA,
Ann Surg Oncol. 2015 Feb;22(2):573-80. doi: 10.1245/s10434-014-4020-z. Epub 2014 Aug 27.
Because duodenal adenocarcinoma (DA) is relatively rare, few studies have investigated the impact of resection type on long-term outcomes.
The Surveillance, Epidemiology, and End Results database was used to identify all patients between 1988 and 2010 with DA. Patients were divided into two groups based on the type of surgery received: simple resection (SR), defined as a simple removal of the primary site, and radical resection (RR), defined as removal of the primary site with a resection in continuity with other organs. Differences in disease-specific survival (DSS) and overall survival (OS) were compared.
Of the 1,611 patients included, 746 (46.3 %) underwent SR and 865 (53.7 %) underwent RR. As expected, patients undergoing RR were more likely to present with poorly differentiated and large tumors, as well as advanced stage disease. Despite greater lymph node (LN) retrieval (11.0 vs. 6.8; p < 0.0001), RR was not associated with improved survival (5-year DSS and OS rates of 52.8 and 41.3 % for SR vs. 48.8 and 37.6 % for RR; p > 0.05). On univariate Cox proportional hazards regression analysis, the type of surgery was not associated with OS (odds ratio [OR] 0.98; 95 % confidence interval [CI] 0.87-1.11). Increasing TNM stages, tumor grade, fewer LNs removed, LN ratio, and absence of radiation were associated with worse survival. After controlling for confounding factors, type of surgery still did not influence OS (OR 1.11; 95 % CI 0.97-1.27).
Radical resection (e.g., in the form of pancreaticoduodenectomy) does not appear to impact survival compared with simple segmental resection for DA.
由于十二指肠腺癌(DA)相对罕见,很少有研究调查切除类型对长期预后的影响。
利用监测、流行病学和最终结果数据库识别1988年至2010年间所有患有DA的患者。根据接受的手术类型将患者分为两组:单纯切除术(SR),定义为单纯切除原发部位;根治性切除术(RR),定义为切除原发部位并与其他器官连续切除。比较疾病特异性生存(DSS)和总生存(OS)的差异。
在纳入的1611例患者中,746例(46.3%)接受了SR,865例(53.7%)接受了RR。正如预期的那样,接受RR的患者更有可能出现低分化和大肿瘤,以及晚期疾病。尽管RR组的淋巴结(LN)清扫数量更多(11.0枚对6.8枚;p<0.0001),但RR与生存率提高无关(SR组的5年DSS和OS率分别为52.8%和41.3%,RR组为48.8%和37.6%;p>0.05)。单因素Cox比例风险回归分析显示,手术类型与OS无关(比值比[OR]0.98;95%置信区间[CI]0.87-1.11)。TNM分期增加、肿瘤分级、切除的LN数量减少、LN比值以及未接受放疗与较差的生存率相关。在控制混杂因素后,手术类型仍不影响OS(OR 1.11;95%CI 0.97-1.27)。
与DA的单纯节段性切除相比,根治性切除(如胰十二指肠切除术形式)似乎对生存没有影响。